The Zacks Analyst Blog Abbott, Taiwan Semiconductor, American Express, ManpowerGroup and D.R. Horton

Zacks
04-15

For Immediate Releases

Chicago, IL – April 15, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Abbott Laboratories ABT, Taiwan Semiconductor Manufacturing Co. TSM, American Express Co. AXP, ManpowerGroup Inc. MAN and D.R. Horton, Inc. DHI.

Here are highlights from Tuesday’s Analyst Blog:

The first quarter earnings season is off and running but this second week is relatively quiet. There will be more big banks, including Bank of America and Citigroup, as well as regional banks reporting.

Additionally, Netflix will be the first big technology and growth company to report of the cycle.

Tariffs and the Consumer

But investors should have a new strategy this earnings season.

It’s not just about the earnings beat, or miss. It’s about two other things: the tariffs and what is happening with the consumer. Some companies will be impacted by the tariffs more than the consumer and vice-versa.

How much are tariffs going to impact earnings? If at all?

Is the consumer pulling back on spending? Or not?

Guidance will be key but with all the uncertainty, will companies even be able to give any guidance beyond the second quarter?

There’s a high level of uncertainty this week. These are the top stock charts to watch.

5 Top Stock Charts for This Week

1. Abbott Laboratories

Abbott Laboratories has only missed one time in the last 5 years and it was back in 2021. That’s an impressive record of beats and meets as it includes the pandemic.

The Zacks Consensus is looking for Abbott Laboratories to grow its earnings by 10.3% in 2025 and another 11.4% in 2026. However, it’s trading with a forward price-to-earnings (P/E) ratio of 24.7. That’s expensive even though shares of Abbot Laboratories are off 2025 highs.

Will Abbott Laboratories beat again?

2. Taiwan Semiconductor Manufacturing Co. Taiwan Semiconductor is an earnings all-star. It has only missed on earnings one time in the last 5 years and it was all the way back in 2020, when the pandemic hit.

Earnings of Taiwan Semiconductor are expected to rise 29% this year and another 21% in 2026. But Taiwan Semiconductor is a Zacks Rank #4 (Sell) as one estimate for 2025 has been cut in the last week. That’s bearish.

Will Taiwan Semiconductor beat again even with all the economic uncertainty?

3. American Express Co. American Express has beat on earnings 4 quarters in a row. However, shares of American Express have fallen 14% year-to-date.

Earnings of American Express are expected to rise 14.1% year-to-date. However, 2 estimates have been cut for 2025 in the last 7 days and none have been raised. Thanks to the shares declining, the company is cheaper than the start of the year. American Express has a forward P/E of 16.5.

American Express has its pulse on consumer spending. What will it say this week?

4. ManpowerGroup Inc. ManpowerGroup has beat on earnings 6 quarters in a row. But that hasn’t stopped the stock from falling to 5-year lows.

ManpowerGroup is a global staffing firm. Earnings are expected to fall 13% in 2025. ManpowerGroup is cheap. It trades with a forward P/E of just 12.9.

Is ManpowerGroup too risky in 2025 with the chance growing of a US recession and global slowdown?

5. D.R. Horton, Inc. D.R. Horton has beat 3 out of the last 4 quarters and has only missed on earnings three times in the last 5 years despite volatility in the housing industry since the pandemic.

Shares of D.R. Horton have fallen 13.5% year-to-date. But analysts also continue to cut earnings estimates for 2025, with one estimate cut in the last week. Earnings of D.R. Horton are expected to fall 10.8% this year.

Why Haven't You Looked at Zacks' Top Stocks?

Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.

Today you can access their live picks without cost or obligation.

See Stocks Free >>

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Previewreports. If you want an email notification each time Sheraz publishes a new article, please click here>>>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                                     

https://www.zacks.com                                                

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance  for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10